ALDH1L1 and non-small cell lung carcinoma: Subsequently, we assessed whether ALDH1L1 could have the potential to be a therapeutic target by analyzing the effect of Aldh1l1 deletion in KrasLA2 mice, a surrogate model of human NSCLC.